SBIR/STTR Research Award
IGF OT IGF SBIR TOPIC THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS BRS FOR THE TREATMENT OF COARCTATION OF THE AORTA IN NEONATES CAN
Award amount
$397,952Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Lyra Therapeutics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- DK48JGAVNMJ1
- Solicitation number
- Not reported
- Topic code
- NHLBI
Research abstract
Aortic coarctation is a common congenital heart condition that is usually recognized during the neonatal period early after birth The usual treatment is open surgery Non surgical catheter based stent therapy is not available to treat neonatal aortic coarctation because children outgrow commercially available metallic stents Absorbable stents might revolutionize the treatment of aortic coarctation in children especially in neonates Neonates require small delivery systems for relatively large nominal diameter implants which is technically challenging No commercial alternatives are available for off label medical use There is a considerable unmet need for a purpose built absorbable scaffold stent for neonatal aortic coarctation
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR TOPIC 096:Novel Biodegradable Stents for Neonatal Aortic Coarctation
- Novel Bioabsorbable, Flexible Polymeric Stent for Pulmonary Artery Stenosis
- IGF OT IGF SBIR TOPIC PHASE II NOVEL BIOABSORBABLE FLEXIBLE POLYMERIC STENT FOR PEDIATRIC CARDIOLOGY
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications
Research funding history
4 SBIR/STTR records share this UEI (2015–2018). Reported award amounts total $6,768,961. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services